These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8554610)

  • 1. Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.
    Webster S; Glabe C; Rogers J
    Biochem Biophys Res Commun; 1995 Dec; 217(3):869-75. PubMed ID: 8554610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and cell association of C1q in Alzheimer's disease brain.
    Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
    Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C1q does not bind monomeric beta-amyloid.
    Snyder SW; Wang GT; Barrett L; Ladror US; Casuto D; Lee CM; Krafft GA; Holzman RB; Holzman TF
    Exp Neurol; 1994 Jul; 128(1):136-42. PubMed ID: 8070518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.
    Webster S; O'Barr S; Rogers J
    J Neurosci Res; 1994 Nov; 39(4):448-56. PubMed ID: 7884823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
    LeVine H
    Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
    Urbányi Z; Forrai E; Sárvári M; Likó I; Illés J; Pázmány T
    Neurochem Int; 2005 May; 46(6):471-7. PubMed ID: 15769549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component C1q modulates the phagocytosis of Abeta by microglia.
    Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
    Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine inhibits amyloid formation by the beta-peptide.
    Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
    Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid.
    Sabaté R; Gallardo M; Estelrich J
    Biopolymers; 2003; 71(2):190-5. PubMed ID: 12767118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
    Webster S; Bonnell B; Rogers J
    Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
    Danielsson J; Pierattelli R; Banci L; Gräslund A
    FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation.
    Bieschke J; Zhang Q; Powers ET; Lerner RA; Kelly JW
    Biochemistry; 2005 Apr; 44(13):4977-83. PubMed ID: 15794636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease].
    Manzano-León N; Mas-Oliva J
    Gac Med Mex; 2006; 142(3):229-38. PubMed ID: 16875352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
    Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
    Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
    [No Abstract]   [Full Text] [Related]  

  • 19. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
    Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
    Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.